SCHEMBL25170451

SCHEMBL25170451

O=C(O)c1cnc(-c2cccc(C(F)(F)F)c2)[nH]1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCN2A Q99250 5/20 0.63
PIN1 Q13526 2/20 0.63
HRH1 P35367 1/20 0.58
HRH4 Q9H3N8 1/20 0.58
NPY5R Q15761 2/20 0.53
KMO O15229 2/20 0.51
PARP1 P09874 1/20 0.48
GRK6 P43250 1/20 0.47
KDM4E B2RXH2 1/20 0.47
MEN1 O00255 1/20 0.47
NPC1 O15118 1/20 0.47
ALDH1A1 P00352 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
THRB P10828 1/20 0.47
CYP2C9 P11712 1/20 0.47
PKM P14618 1/20 0.47
HPGD P15428 1/20 0.47
TSHR P16473 1/20 0.47
STAT6 P42226 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30371688 1.00 SCN2A (0.63) SCN2APIN1HRH1HRH4NPY5R
SCHEMBL3057838 0.78 PIN1 (1.00) SCN2APIN1NPY5RCYP1A2
SCHEMBL23846978 0.78 PIN1 (0.69) SCN2APIN1HRH1NPY5RKMO
SCHEMBL25174438 0.78 SCN2A (0.72) SCN2AHRH1HRH4NPY5RKDM4E
SCHEMBL23736211 0.77 SCN2A (0.70) SCN2APIN1HRH1HRH4NPY5R
SCHEMBL15332010 0.76 SCN2A (0.65) SCN2APIN1HRH1HRH4NPY5R
SCHEMBL28540057 0.75 SCN2A (1.00) SCN2AHRH1HRH4NPY5R
SCHEMBL25754934 0.75 PIN1 (0.63) SCN2APIN1NPY5RPARP1GRK6
SCHEMBL3227740 0.74 KMO (0.56) SCN2APIN1KMOPARP1KDM4E
SCHEMBL11624684 0.72 SCN2A (0.59) SCN2AHRH1HRH4NPY5RKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023081662-A1 BICYCLIC DERIVATIVES AS CCR2 MODULATORS ARIA PHARMACEUTICALS, INC. (US) 2023-05-11 WO disclosed
WO-2023081662-A1 BICYCLIC DERIVATIVES AS CCR2 MODULATORS ARIA PHARMACEUTICALS, INC. (US) 2023-05-11 WO disclosed